Hazel Dockrell News Today : Breaking News, Live Updates & Top Stories | Vimarsana

The research was conducted on 144 patients with type 1 diabetes at the start of the pandemic

Researchers at Massachusetts General Hospital (MGH), published a new paper in Cell Reports Medicine demonstrating the protective potential of multiple doses of the Bacillus Calmette-Guerin (BCG)...

No new vaccine for TB developed since BCG was first used 100 years ago

On July 18, 1921, the first infant was inoculated with a live bovine strain of bacteria ( Mycobacterium bovis). His mother had died from an infection with the closely related human pathogen M. tuberculosis following his birth at a Paris hospital a few hours earlier. The child’s grandmother, who would care for him, also had tuberculosis (TB). In an attempt to protect the newborn from the disease, doctors gave him an oral dose of what was later named Bacille Calmette-Guérin (BCG) vaccine, for its developers Albert Calmette and Camille Guérin. The duo had cultured M. bovis for more than a ...

The East African Wednesday February 24 2021 Summary Study says that when given at the right time,  the Bacillus Calmette-Guerin (BCG), could protect newborns against a variety of common conditions such as upper respiratory tract infections, chest complications like pneumonia or bronchitis, diarrhoea and potentially Covid-19. Advertisement Vaccines save lives and have been instrumental in preventing a myriad of infections that would otherwise cause undue suffering and death in children. In Kenya, the extended immunisation programme has played a key role in reducing deaths among infants from ...